Poseida Therapeutics
San Diego
About Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $460.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2023)
- Ticker: nasdaq:PSTX
- Website: poseida.com
- Phone: (858)-779-3100
Industries & Categories
Biopharma, Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/poseida-therapeutics-54754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.